Frazier Life Sciences VIII, L.P.

Insider Reports History

Entity
Company
Location
601 Union Street, Suite 3200, Seattle, WA
Signature
Frazier Life Sciences VIII, L.P., By: FHM Life Sciences VIII, L.P., its general partner, By: FHM Life Sciences VIII, L.L.C., its general, partner, By: /s/ Steve R. Bailey, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frazier Life Sciences VIII, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcutis Biotherapeutics, Inc. 10%+ Owner Common Stock 8.76M $31M $3.54 Oct 24, 2023 Direct
ALPINE IMMUNE SCIENCES, INC. 10%+ Owner Common Stock 1.48M $18.9M $12.74 Feb 11, 2022 Direct
Arcutis Biotherapeutics, Inc. 10%+ Owner Common Stock 23.7K $83.9K $3.54 Oct 24, 2023 By The Heron Living Trust 11/30/2004
Arcutis Biotherapeutics, Inc. 10%+ Owner Common Stock 19.4K $68.6K $3.54 Oct 24, 2023 By Topper Family Revocable Trust
Arcutis Biotherapeutics, Inc. 10%+ Owner Common Stock 11.3K $39.9K $3.54 Oct 24, 2023 By Topper Group II LLC
Arcutis Biotherapeutics, Inc. 10%+ Owner Common Stock 8.69K $30.8K $3.54 Oct 24, 2023 By Patrick J. Heron
Arcutis Biotherapeutics, Inc. 10%+ Owner Common Stock 7 $24.80 $3.54 Oct 24, 2023 FHM Life Sciences VIII, L.L.C.

Insider Reports Filed by Frazier Life Sciences VIII, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARQT Arcutis Biotherapeutics, Inc. Oct 24, 2023 1 $200K 4 Oct 26, 2023 10%+ Owner
ARQT Arcutis Biotherapeutics, Inc. Aug 5, 2022 1 $5M 4 Aug 9, 2022 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Feb 11, 2022 1 $800K 4 Feb 15, 2022 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Sep 17, 2021 2 $0 4 Sep 21, 2021 10%+ Owner
ARQT Arcutis Biotherapeutics, Inc. May 10, 2021 3 $0 4 May 12, 2021 10%+ Owner